Fundraising through the 8th and 9th Series Stock Acquisition Rights
First written in FY2020-Q1. 4 of 7 entries say "Advanced", first in FY2020-Q2. Latest entry: 2026-10-29.
7 other companies' latest entry also says "First stated".
- FY2025-H1RestatedAnnual report
「Although the company expects to secure a certain amount of funding through the sale of inventory products it holds, it will continue to consider and discuss a broad range of funding options, including equity and debt financing, to further develop its businesses.」
The company's funding policy is to consider and discuss a broad range of financing options, including equity and debt financing, in addition to securing funds through inventory sales. - FY2020AdvancedAnnual report
「This was attributable to proceeds of ¥564.672 million from the issuance of shares upon the exercise of stock acquisition rights, among other items.」
Exercise of the 8th and 9th series of stock acquisition rights progressed throughout the fiscal year, generating ¥564.672 million in proceeds from share issuance and increasing the number of shares outstanding by 1,600,000. - FY2020-Q3AdvancedAnnual report
「During the third quarter accounting period, the number of the relevant stock acquisition rights with provisions for adjustment of the exercise price that were exercised was 600,000 units of the 8th series and 466,000 units of the 9th series.」
During the quarter, a total of 1,066,000 units of the 8th and 9th series of stock acquisition rights were exercised, and the same number of shares was issued. Total proceeds were ¥397.501 million. - FY2020-Q2AdvancedAnnual report
「During the second quarter accounting period, the number of the relevant stock acquisition rights with provisions for adjustment of the exercise price that were exercised was 200,000 units of the 8th series and 334,000 units of the 9th series.」
A total of 534,000 units of the 8th and 9th series of stock acquisition rights were exercised, resulting in the issuance of 534,000 shares and total proceeds of ¥170.986 million. - FY2020-Q1First statedAnnual report
「A resolution was passed to issue the 8th series and 9th series of stock acquisition rights through a third-party allotment, each with a provision for adjustment of the exercise price.」
At a board meeting held on 14 February 2020, the company resolved to issue 800,000 units each of the 8th and 9th series of stock acquisition rights. EVO FUND was the allottee for the 8th series and 株式会社ユニ・ロット for the 9th series. Estimated net proceeds were ¥464.474 million and ¥465.842 million, respectively, and the exercise period was set from 10 March to 10 September 2020.